8 September, 2022
PanPath B.V. is currently extending its product line with novel FISH assays such as: gene amplifications (i.e. MDM2, EFGR), genetic rearrangements (i.e. RET, PLAG1), chromosomal imbalance (i.e. 3pter/3qter), various microdeletion […]
1 April, 2022
Today marks the 20th anniversary of PanPath! On April 1st 2002, Frans Kwaspen founded PanPath B.V. To celebrate with you, we are excited to announce that this year we will […]